# A Novel Pharmacological Therapy for Obstructive Sleep Apnea

> **NCT03919955** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 117 (actual)

## Conditions studied

- Sleep Apnea

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Oxybutynin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03919955
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-03
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-09-07
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919955, "A Novel Pharmacological Therapy for Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03919955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*